Screening for von Willebrand disease in pregnant women with self-reported bleeding histories in Southeast Nigeria
Open Access
- 31 July 2024
- journal article
- Published by Medknow in Advances in Biomedical and Health Sciences
- Vol. 3 (3) , 143-151
Abstract
Background: Menorrhagia affects 18 million women globally aged 30–55 years and poses a significant health concern. This study assessed the coagulation profile of pregnant women with bleeding problems who were screened for von Willebrand Disease (VWD). Methods: This cross-sectional study included 150 pregnant women from the Odumegwu Ojukwu University and Enugu State University Teaching Hospitals. Forty-five age-matched nonpregnant women served as controls. Blood samples were collected for coagulation studies, complete blood counts, and measurement of von Willebrand factor parameters. Data were collected from January 2021 to August 2022, and bleeding severity was assessed using the International Society for Thrombosis and Haemostasis-Bleeding Assessment Tool. Categorical variables are represented as frequencies and percentages. The Kruskal–Wallis test and descriptive statistics were performed for continuous variables. Dunn’s multiple comparison test was performed for the groups, whereas the Mann–Whitney U test was used for the two groups. Statistical significance was set at P < 0.05. Results: Postpartum hemorrhage (38%) was the most prevalent symptom. Levels of VWF: Ag, FVIII, and VWF:CB increased as pregnancy progressed but were significantly lower in pregnant women with a history of bleeding. A low FVIII:C/VWF:Ag ratio (F8 and VWF genes. A low discordance (<0.7) VWF:CB/Ag ratio may indicate VWD types 2A, 2B, 2M, or PT. Conclusion: Thus, additional evaluations using assays such as ristocetin-induced platelet aggregation, multimer analysis, and genetic testing are needed, although these may be unavailable in resource-limited settings.Keywords
This publication has 50 references indexed in Scilit:
- Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosingThrombosis Research, 2019
- Evaluating errors in the laboratory identification of von Willebrand disease in the real worldThrombosis Research, 2014
- Evaluation of bleeding disorders in women with menorrhagia: a survey of obstetrician-gynecologistsAmerican Journal of Obstetrics and Gynecology, 2012
- WHO analysis of causes of maternal death: a systematic reviewThe Lancet, 2006
- Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in IranAmerican Journal of Hematology, 2004
- Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell diseaseAnnals of Hematology, 2004
- Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up dataAmerican Journal of Obstetrics and Gynecology, 2004
- Haemostasis in normal and abnormal pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2003
- A survey of women's experiences of vaginal loss from 24 hours to three months after childbirth (the BLiPP study)Midwifery, 1999
- Factor XI deficiency in womenAmerican Journal of Hematology, 1999